NCT07506044 Dexmedetomidine as an Adjuvant During Dural Puncture Epidural
| NCT ID | NCT07506044 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Menoufia University |
| Condition | Total Dose of Bupivacaine Administered During Labor |
| Study Type | INTERVENTIONAL |
| Enrollment | 140 participants |
| Start Date | 2026-05-30 |
| Primary Completion | 2026-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 140 participants in total. It began in 2026-05-30 with a primary completion date of 2026-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study aimed to determine the effects of using varied doses of DEX on the concentration of bupivacaine injected for epidural labor analgesia, and to assess the benefits of the dural puncture epidural.
Eligibility Criteria
Inclusion Criteria: * Women who attend the Emergency Department in labor, with cervical dilation of 3-5 cm, * normally presented singleton fetus, intact fetal membranes, and who are free of exclusion criteria Exclusion Criteria: Abnormal fetal presentation or lie, 'premature rupture of membranes, maternal fever, fetal distress, pregnancy-induced diseases * abnormal placental position, * ASA grade\>II * marked obesity, * allergy or contraindications to the used drugs, * spinal deformity or disorders 'cutaneous diseases or infection at the injection site
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07506044 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 40 Years, studying Total Dose of Bupivacaine Administered During Labor. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07506044 currently recruiting?
Yes, NCT07506044 is actively recruiting participants. Contact the research team at rabab_habeeb@med.menofia.edu.eg for enrollment information.
Where is the NCT07506044 trial being conducted?
This trial is being conducted at Shebeen El Kom, Egypt.
Who is sponsoring the NCT07506044 clinical trial?
NCT07506044 is sponsored by Menoufia University. The trial plans to enroll 140 participants.